Kronos Bio, Inc.
KRON
$0.88
$0.01291.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.60% | -82.95% | 12.90% | 45.93% | -18.32% |
| Total Depreciation and Amortization | -46.21% | -0.73% | -1.90% | -11.58% | -0.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.01% | 763.26% | -24.68% | -80.65% | 177.33% |
| Change in Net Operating Assets | -50.13% | -611.62% | 77.53% | 61.67% | -62.32% |
| Cash from Operations | -0.05% | -3.75% | 24.24% | 31.67% | 4.50% |
| Capital Expenditure | -- | -157.14% | -- | 100.00% | 77.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.25% | 30.62% | -57.38% | 595.45% | -81.71% |
| Cash from Investing | -11.23% | 30.54% | -57.37% | 596.29% | -81.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 8,300.00% | -100.61% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.07% | 101.96% | -80.19% | 232.44% | -369.50% |